Two_CD
distinct_JJ
pathways_NNS
of_IN
interleukin-5_NN
synthesis_NN
in_IN
allergen-specific_JJ
human_JJ
T-cell_NN
clones_NNS
are_VBP
suppressed_VBN
by_IN
glucocorticoids_NNS
._.

Glucocorticoids_NNS
-LRB-_-LRB-
GC_NN
-RRB-_-RRB-
have_VBP
long_RB
been_VBN
used_VBN
as_IN
the_DT
most_RBS
effective_JJ
agents_NNS
for_IN
the_DT
treatment_NN
of_IN
allergic_JJ
diseases_NNS
accompanied_VBN
by_IN
eosinophilia_NN
such_JJ
as_IN
chronic_JJ
asthma_NN
and_CC
atopic_JJ
dermatitis_NN
._.

The_DT
development_NN
of_IN
chronic_JJ
eosinophilic_JJ
inflammation_NN
is_VBZ
dependent_JJ
on_IN
interleukin-5_NN
-LRB-_-LRB-
IL-5_NN
-RRB-_-RRB-
,_,
a_DT
selective_JJ
eosinophil-activating_JJ
factor_NN
,_,
produced_VBN
by_IN
helper_NN
T_NN
cells_NNS
._.

To_TO
delineate_VB
the_DT
regulatory_JJ
mechanisms_NNS
of_IN
human_JJ
IL-5_NN
synthesis_NN
,_,
we_PRP
established_VBD
allergen-specific_JJ
CD4_NN
+_CC
T-cell_NN
clones_NNS
from_IN
asthmatic_JJ
patients_NNS
._.

GC_NN
efficiently_RB
suppressed_VBD
IL-5_NN
synthesis_NN
of_IN
T-cell_NN
clones_NNS
activated_VBN
via_IN
either_CC
T-cell_NN
receptor_NN
-LRB-_-LRB-
TCR_NN
-RRB-_-RRB-
or_CC
IL-2_NN
receptor_NN
-LRB-_-LRB-
IL-2R_NN
-RRB-_-RRB-
._.

Induction_NN
of_IN
IL-5_NN
mRNA_NN
upon_IN
TCR_NN
and_CC
IL-2R_NN
stimulation_NN
was_VBD
totally_RB
inhibited_VBN
by_IN
dexamethasone_NN
._.

Human_JJ
IL-5_NN
promoter\/enhancer-luciferase_NN
gene_NN
construct_NN
transfected_VBN
to_TO
T-cell_NN
clones_NNS
was_VBD
transcribed_VBN
on_IN
either_CC
TCR_NN
or_CC
IL-2R_NN
stimulation_NN
and_CC
was_VBD
clearly_RB
downregulated_VBN
by_IN
dexamethasone_NN
,_,
indicating_VBG
that_IN
the_DT
approximately_RB
500-bp_JJ
human_JJ
IL-5_NN
gene_NN
segment_NN
located_JJ
5_CD
'_''
upstream_JJ
of_IN
the_DT
coding_NN
region_NN
contains_VBZ
activation-inducible_JJ
enhancer_NN
elements_NNS
responsible_JJ
for_IN
the_DT
regulation_NN
by_IN
GC_NN
._.

Electrophoretic_JJ
mobility_NN
shift_NN
assay_NN
analysis_NN
suggested_VBD
that_IN
AP-1_NN
and_CC
NF-kappaB_NN
are_VBP
among_IN
the_DT
possible_JJ
targets_NNS
of_IN
GC_NN
actions_NNS
on_IN
TCR-stimulated_JJ
T_NN
cells_NNS
._.

NF-AT_NN
and_CC
NF-kappaB_NN
were_VBD
not_RB
significantly_RB
induced_VBN
by_IN
IL-2_NN
stimulation_NN
._.

Our_PRP$
results_NNS
showing_VBG
that_IN
GC_NN
suppressed_VBD
IL-5_NN
production_NN
by_IN
human_JJ
CD4_NN
+_CC
T_NN
cells_NNS
activated_VBN
by_IN
two_CD
distinct_JJ
stimuli_NNS
,_,
TCR_NN
and_CC
IL-2R_NN
stimulation_NN
,_,
underscore_VBP
the_DT
efficacy_NN
of_IN
GC_NN
in_IN
the_DT
treatment_NN
of_IN
allergic_JJ
diseases_NNS
via_IN
suppression_NN
of_IN
T-cell_NN
IL-5_NN
synthesis_NN
._.

